CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
BreEStim +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03302793
NCT03302793N/ACompleted
CompareCT.gov

Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management

The University of Texas Health Science Center, Houston·interventional·Posted Oct 5, 2017·Updated Jan 24, 2019

In Brief

A clinical study evaluating BreEStim, tDCS, and 1 other intervention for Pain Management. Completed, enrolled 12 participants across 1 site.

Detailed Summary

This study looks at the effect of combined breathing-controlled electrical stimulation (BreEStim) and transcranial direct current stimulation (tDCS) on neuropathic pain after spinal cord injury, amputation, or brain injury. The hypothesis is that a single session of combined BreEStim and tDCS will produce an additive analgesic effect. This record covers the study in a population of spinal cord injury patients. Note that this study will also enroll healthy volunteers, brain injury patients, and amputation patients and that this study as applied to these other populations will be covered in separate ClinicalTrials.gov records.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain Management
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 5, 2017
Enrollment StartApr 1, 2015
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 8.7 years ago

Interventions

BreEStimdevice

BreEStim will applied for 10 to 20 minutes.

tDCSdevice

tDCS will be applied for 20 minutes.

tDCS shamdevice